Figure 2From: Potential antitumor effects of nitrogen-containing bisphosphonate in hormone receptor negative breast cancer patients with bone metastases Patients with HR positive metastatic bone disease. (A) TTP_BD (P = 0.117), (B) OS (P = 0.104).Back to article page